Inconvenient relationship of haemoglobin A1c level with endothelial function in type 2 diabetes in a cross-sectional study.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
09 06 2021
Historique:
entrez: 10 6 2021
pubmed: 11 6 2021
medline: 22 6 2021
Statut: epublish

Résumé

The aim of this study was to determine the relationship of haemoglobin A1c (HbA1c) level with flow-mediated vasodilation (FMD) and nitroglycerine-induced vasodilation (NID) in patients with type 2 diabetes. Cross-sectional study. 22 university hospitals and affiliated clinics in Japan. 1215 patients with type 2 diabetes including 349 patients not taking antidiabetic drugs. We evaluated FMD and HbA1c level. All patients were divided into four groups based on HbA1c level: <6.5%, 6.5%-6.9%, 7.0%-7.9% and ≥8.0%. An inverted U-shaped pattern of association between HbA1c level and FMD was observed at the peak of HbA1c of about 7%. FMD was significantly smaller in the HbA1c <6.5% group than in the HbA1c 6.5%-6.9% group and HbA1c 7.0%-7.9% group (p<0.001 and p<0.001), and FMD values were similar in the HbA1c <6.5% group and HbA1c ≥8.0% group. There were no significant differences in NID values among the four groups. After adjustments for confounding factors, FMD was significantly smaller in the HbA1c <6.5% group than in the HbA1c 6.5%-6.9% and HbA1c 7.0%-7.9% group (p=0.002 and p=0.04). In patients not taking antidiabetic drugs, FMD was also significantly smaller in the HbA1c <6.5% group than in the HbA1c 6.5%-6.9% group and HbA1c 7.0%-7.9% group (p<0.001 and p=0.02), and there were no significant differences in NID values among the four groups. These findings suggest that there is an inverted U-shaped pattern of association between FMD and HbA1c and that a low HbA1c level of <6.5% is associated with endothelial dysfunction. UMIN000012950, UMIN000012951, UMIN000012952 and UMIN000003409.

Identifiants

pubmed: 34108164
pii: bmjopen-2020-045415
doi: 10.1136/bmjopen-2020-045415
pmc: PMC8191618
doi:

Substances chimiques

Glycated Hemoglobin A 0

Banques de données

UMIN-CTR
['UMIN000012950', 'UMIN000012951', 'UMIN000012952', 'UMIN000003409']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e045415

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

N Engl J Med. 2010 Oct 7;363(15):1410-8
pubmed: 20925543
Pharmacol Ther. 2004 Apr;102(1):87-96
pubmed: 15056500
Diabetes Care. 1993 Feb;16(2):434-44
pubmed: 8432214
Cardiovasc Diabetol. 2014 Jul 30;13:110
pubmed: 25074318
Eur Heart J. 2006 Jul;27(13):1605-9
pubmed: 16762982
Int J Cardiol. 2018 Mar 1;254:284-290
pubmed: 29407110
Int J Cardiol. 2017 Aug 15;241:30-34
pubmed: 28341376
Heart. 2013 Dec;99(24):1837-42
pubmed: 24153417
Diabetes Care. 2018 Jan;41(Suppl 1):S13-S27
pubmed: 29222373
Diabetes Res Clin Pract. 1995 May;28(2):103-17
pubmed: 7587918
BMJ. 2000 Aug 12;321(7258):405-12
pubmed: 10938048
N Engl J Med. 2018 Aug 16;379(7):633-644
pubmed: 30110583
Diabetes Metab Res Rev. 2008 Jul-Aug;24(5):353-63
pubmed: 18461635
J Clin Hypertens (Greenwich). 2018 May;20(5):910-917
pubmed: 29729072
Am J Physiol. 1990 Jun;258(6 Pt 2):H1775-9
pubmed: 1972868
Circ J. 2009 Mar;73(3):411-8
pubmed: 19194043
Atherosclerosis. 2004 May;174(1):49-56
pubmed: 15135250
J Diabetes Complications. 2006 Nov-Dec;20(6):395-401
pubmed: 17070446
Am J Hypertens. 2002 Apr;15(4 Pt 1):302-9
pubmed: 11991214
Arterioscler Thromb Vasc Biol. 2011 Oct;31(10):2353-9
pubmed: 21737782
Chest. 2004 Mar;125(3):823-30
pubmed: 15006938
N Engl J Med. 2010 Jul 15;363(3):233-44
pubmed: 20587587
Hypertension. 1999 Jan;33(1 Pt 2):591-7
pubmed: 9931171
Diabetologia. 1996 Dec;39(12):1540-5
pubmed: 8960840
PLoS One. 2012;7(6):e38877
pubmed: 22719972
Int Heart J. 2012;53(3):170-5
pubmed: 22790685
Ann Intern Med. 2004 Sep 21;141(6):413-20
pubmed: 15381514
J Korean Med Sci. 2012 Nov;27(11):1364-70
pubmed: 23166419
N Engl J Med. 2008 Jun 12;358(24):2545-59
pubmed: 18539917
Nature. 2001 Dec 13;414(6865):813-20
pubmed: 11742414
Arch Endocrinol Metab. 2017 Dec;61(6):542-549
pubmed: 28724057
Arterioscler Thromb Vasc Biol. 2013 Jun;33(6):1401-8
pubmed: 23520168
Rev Diabet Stud. 2014 Summer;11(2):138-52
pubmed: 25396402
Circulation. 2003 Aug 5;108(5):530-5
pubmed: 12874192
Diabetes Care. 2017 Apr;40(4):453-460
pubmed: 28223299
Circulation. 2009 Aug 11;120(6):502-9
pubmed: 19635967
JAMA. 2001 May 16;285(19):2486-97
pubmed: 11368702
J Am Coll Cardiol. 1996 Mar 1;27(3):567-74
pubmed: 8606266
N Engl J Med. 2009 Jan 8;360(2):129-39
pubmed: 19092145
N Engl J Med. 2008 Jun 12;358(24):2560-72
pubmed: 18539916
J Am Coll Cardiol. 2016 Feb 2;67(4):456-458
pubmed: 26821636
Eur Heart J. 2013 Oct;34(40):3137-44
pubmed: 23999452

Auteurs

Takayuki Yamaji (T)

Department of Cardiovascular Medicine, Hiroshima University Faculty of Medicine Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.

Takahiro Harada (T)

Department of Cardiovascular Medicine, Hiroshima University Faculty of Medicine Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.

Yu Hashimoto (Y)

Department of Cardiovascular Medicine, Hiroshima University Faculty of Medicine Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.

Yuji Takaeko (Y)

Department of Cardiovascular Medicine, Hiroshima University Faculty of Medicine Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.

Masato Kajikawa (M)

Division of Regeneration and Medicine, Medical Center for Translational and Clinical Research, Hiroshima University Hospital, Hiroshima, Japan.

Yiming Han (Y)

Department of Cardiovascular Medicine, Hiroshima University Faculty of Medicine Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.

Tatsuya Maruhashi (T)

Department of Cardiovascular Regeneration and Medicine, Hiroshima University Research Institute for Radiation Biology and Medicine, Hiroshima, Japan.

Shinji Kishimoto (S)

Department of Cardiovascular Regeneration and Medicine, Hiroshima University Research Institute for Radiation Biology and Medicine, Hiroshima, Japan.

Haruki Hashimoto (H)

Department of Cardiovascular Medicine, Hiroshima University Faculty of Medicine Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.

Yasuki Kihara (Y)

Department of Cardiovascular Medicine, Hiroshima University Faculty of Medicine Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.

Eisuke Hida (E)

Graduate School of Medicine Department of Biostatistics and Data Science, Osaka University, Suita, Japan.

Kazuaki Chayama (K)

Department of Gastroenterology and Metabolism, Hiroshima University Faculty of Medicine Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.

Chikara Goto (C)

Department of Rehabilitation, Hiroshima International University, Higashihiroshima, Japan.

Farina Mohamad Yusoff (FM)

Department of Cardiovascular Regeneration and Medicine, Hiroshima University Research Institute for Radiation Biology and Medicine, Hiroshima, Japan.

Ayumu Nakashima (A)

Department of Stem Cell Biology and Medicine, Hiroshima University Faculty of Medicine Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.

Yukihito Higashi (Y)

Division of Regeneration and Medicine, Medical Center for Translational and Clinical Research, Hiroshima University Hospital, Hiroshima, Japan yhigashi@hiroshima-u.ac.jp.
Department of Cardiovascular Regeneration and Medicine, Hiroshima University Research Institute for Radiation Biology and Medicine, Hiroshima, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH